These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24035688)

  • 1. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
    Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we treat the brain in glaucoma?
    Gupta N; Yücel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective therapies for glaucoma.
    Song W; Huang P; Zhang C
    Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
    Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA
    Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper.
    Tamm ER; Schmetterer L; Grehn F
    Cell Tissue Res; 2013 Aug; 353(2):347-54. PubMed ID: 23712457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
    Haefliger IO; Fleischhauer JC; Flammer J
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():464-72. PubMed ID: 11026975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rasagiline-induced delay of retinal ganglion cell death in experimental glaucoma in rats.
    Levkovitch-Verbin H; Vander S; Melamed S
    J Glaucoma; 2011; 20(5):273-7. PubMed ID: 20577110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
    Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
    Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering.
    Tribble JR; Hui F; Quintero H; El Hajji S; Bell K; Di Polo A; Williams PA
    Mol Aspects Med; 2023 Aug; 92():101193. PubMed ID: 37331129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging medical therapies in the treatment of glaucoma.
    Bagnis A; Papadia M; Scotto R; Traverso CE
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
    Attarzadeh A; Hosseini H; Nowroozizadeh S
    Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
    Thanos S; Naskar R
    Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.